Document Detail


No-reflow protection and long-term efficacy for acute myocardial infarction with Tongxinluo: a randomized double-blind placebo-controlled multicenter clinical trial (ENLEAT Trial).
MedLine Citation:
PMID:  21034597     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: No-reflow after emergency percutaneous coronary intervention (PCI) for acute ST segment elevation myocardial infarction (STEMI) is related to the severe prognosis. The aim of this study was to evaluate the efficacy of Tongxinluo, a traditional Chinese medicine, on no-reflow and the infarction area after emergency PCI for STEMI.
METHODS: A total of 219 patients (female 31, 14%) undergoing emergency PCI for STEMI from nine clinical centers were consecutively enrolled in this randomized, double-blind, placebo-controlled, multicenter clinical trial from January 2007 to May 2009. All patients were randomly divided into Tongxinluo group (n = 108) and control group (n = 111), given Tongxinluo or placebo in loading dose 2.08 g respectively before emergency PCI with aspirin 300 mg and clopidogrel 300 mg together, then 1.04 g three times daily for six months after PCI. The ST segment elevation was recorded by electrocardiogram at hospitalization and 1, 2, 6, 12, 24 hours after coronary balloon dilation to evaluate the myocardial no-flow; myocardial perfusion scores of 17 segments were evaluated on day 7 and day 180 after STEMI with static single-photon emission computed tomography (SPECT) to determine the infarct area.
RESULTS: There was no statistical significance in sex, age, past history, chest pain, onset-to-reperfusion time, Killip classification, TIMI flow grade just before and after PCI, either in the medication treatment during the follow up such as statin, β-blocker, angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) between two groups. There was significant ST segment restoration in Tongxinluo group compared to the control group at 6 hours ((-0.22 ± 0.18) mV vs. (-0.18 ± 0.16) mV, P = 0.0394), 12 hours ((-0.24 ± 0.18) mV vs. (-0.18 ± 0.15) mV, P = 0.0158) and 24 hours ((-0.27 ± 0.16) mV vs. (-0.20 ± 0.16) mV, P = 0.0021) reperfusion; and the incidence of myocardial no-reflow was also reduced significantly at 24-hour reperfusion (34.3% vs. 54.1%, P = 0.0031). The myocardial perfusion scores of 17 segments evaluated by static SPECT was improved significantly on day 7 and day 180 after STEMI in Tongxinluo group compared to the control group (0.61 ± 0.40 vs. 0.76 ± 0.42, P = 0.0109 and 0.51 ± 0.42 vs. 0.66 ± 0.43, P = 0.0115, respectively). There was no significant difference in severe adverse events between two groups.
CONCLUSION: Tongxinluo as a kind of traditional Chinese medicine could reduce myocardial no-reflow and infarction area significantly after emergency PCI for STEMI with conventional medicine therapy.
Authors:
Hai-tao Zhang; Zhen-hua Jia; Jian Zhang; Zan-kai Ye; Wei-xian Yang; Yue-qin Tian; Xuan Jia; Wei Li; Yi-ling Wu; Yue-jin Yang
Related Documents :
23192757 - Evolution of reperfusion therapies for acute brain and acute myocardial ischemia: a sys...
18848177 - Troponin ratio and risk stratification in subjects with acute coronary syndrome undergo...
22955687 - Noncompaction cardiomyopathy : is it more than noncompaction?
15592577 - Therapeutic potential of monteplase in acute myocardial infarction as a powerful thromb...
10740137 - Statins: effective antiatherosclerotic therapy.
11712287 - Analysis of t-wave abnormalities associated with myocardial infarction using a theoreti...
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  Chinese medical journal     Volume:  123     ISSN:  0366-6999     ISO Abbreviation:  Chin. Med. J.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-11-01     Completed Date:  2011-03-03     Revised Date:  2011-08-25    
Medline Journal Info:
Nlm Unique ID:  7513795     Medline TA:  Chin Med J (Engl)     Country:  China    
Other Details:
Languages:  eng     Pagination:  2858-64     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Fuwai Hospital and Cardiovascular Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Aged
Coronary Circulation*
Double-Blind Method
Drugs, Chinese Herbal / therapeutic use*
Electrocardiography
Female
Humans
Male
Medicine, Chinese Traditional
Middle Aged
Myocardial Infarction / drug therapy*,  physiopathology
Tomography, Emission-Computed, Single-Photon
Chemical
Reg. No./Substance:
0/Drugs, Chinese Herbal; 0/tongxinluo
Comments/Corrections
Comment In:
Chin Med J (Engl). 2011 Jun;124(11):1688   [PMID:  21740778 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Voxel-based statistical analysis of cerebral glucose metabolism in patients with permanent vegetativ...
Next Document:  Surgical strategies for petroclival meningioma in 57 patients.